Health
Novartis Secures Milestone in Multiple Sclerosis Treatment
By Editor • September 1, 2026 • 1 min read
Novartis makes strides in multiple sclerosis treatment with a new BTK inhibitor, while Alumis faces setbacks in lupus trials.
Read more